Table 1. Summary of Observed Drug Effects in the Cardiac MPS for Two Cell Lines and Literature Values from Other 3D hiPSC CM Tissue Formats.
drug | studies | TdP risk | Cmax (μM) | prediction | cAPD80 | triangulation | arrhythmia or no beating | matches prediction? |
---|---|---|---|---|---|---|---|---|
dofetilide | MPS WTC | high | 0.002 | ↑ QT, ↑TdP20 | ↑ 0.0001 μM | ↑ 0.0001–0.001 μM | ↑ 0.01–1 μM | yes |
MPS SCVI20 | ↑ 0.01 μM | ↑ 0.1 μM | ↑ 0.01–1 μM | yes | ||||
Biowire31 | ↑ 10–1000 nM | yes | ||||||
tissue rings32 | ↑25a nM32 | yes | ||||||
bepridil | MPS WTC | high | 0.032 | ↑ QT, ↑TdP20 | ↑ 0.0032–3.2 μM | ↑ 3.2–32 μM | N/A | partly (QT) |
MPS SCVI20 | N/A | N/A | ↑ 32 μM | partly (TdP) | ||||
amiodarone | MPS WTC | intermed | 0.0008 | ↑ QT, ↑TdP5 | ↑ 0.01–1 μM | N/A | N/A | partly (QT) |
MPS SCVI20 | N/A | N/A | ↑ 0.01–1 μM | partly (TdP) | ||||
terfenadine | MPS WTC | intermed | 0.00028 | ↑ QT, ↑TdP5,20 | N/A | N/A | ↑ 0.3–3 μM | yes |
MPS SCVI20 | ↓ Dose5 | N/A | ↑ 0.003–3 μM | yes | ||||
anisotropy strip33 | ↑ reentry events 300 nMa | yes | ||||||
nifedipine | MPS WTC | low | 0.0077 | ↑TdP20 | ↓ 0.1–1 μM | ↑ 1 μM | N/A | yes |
MPS SCVI20 | N/A | ↑ 10 μM | ↑ 0.1–10 μM | yes | ||||
tissue rings30 | ↑ 30 nM–1 μMa30 | yes | ||||||
mexiletine | MPS WTC | low | 2.5 | ↓ QT,11INaL block | N/A | ↑ 100 μM | ↑ 100–1000 μM | yes |
MPS SCVI20 | ↓ 100 μM | ↑ 100 μM | ↑ 100–1000 μM | yes | ||||
lidocaine | MPS WTC | low | 2.5 | N/A,5INaL block | N/A | N/A | ↑ 100–1000 μM | yes |
MPS SCVI20 | N/A | N/A | ↑ 1000 μM | yes | ||||
tissue rings34 | no arrhythmia events 100 μMa | yes |
Parameter available in the literature not identical to the parameter used in this publication but comparable.